BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld
Home
» 'Dramatic' impact: Investment in cell, gene therapy skyrockets in 2018, as the sector matures
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
'Dramatic' impact: Investment in cell, gene therapy skyrockets in 2018, as the sector matures
Jan. 11, 2019
By
Nuala Moran
No Comments
LONDON – Cell and gene therapy powered ahead across the globe in 2018, with companies in the sector raising $13.3 billion, an increase of 73 percent over $7.5 billion raised in 2017, and more than three times the 2016 total of $4.2 billion.
BioWorld